Puma Biotech Is Wounded, But May Have Claws: JP Morgan

By: via Benzinga
The share price of Puma Biotechnology, Inc. (NYSE: PBYI) has decline more than 53 percent year-to-date after having achieved a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.